Display revised anti-cancer drug prices prominently: NPPA
Drug prices regulator, National Pharmaceutical Pricing Authority (NPPA), has called for strict monitoring of the implementation of trade margin rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, notified on…
Attributed summary
Drug prices regulator, National Pharmaceutical Pricing Authority (NPPA), has called for strict monitoring of the implementation of trade margin rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, notified on Oct 17 with revised prices effective Nov 9.
Read the original report — Times of India India
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.
